MedAvail Holdings, Inc (MDVL) Tops Q2 EPS by 10c

MedAvail Holdings, Inc (NASDAQ: MDVL) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.52 million.

For earnings history and earnings-related data on MedAvail Holdings, Inc (MDVL) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Dare Bioscience (DARE) Tops Q2 EPS by 11c
• Calamp Corp. (CAMP) Misses Q2 EPS by 33c